Artal Group’s Xenon Pharmaceuticals XENE Stock Holding History

Artal Group’s Portfolio XENE Stock Details XENE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$14.9M	Buy
2024 Q1	$10.9M	Buy
2018 Q4	–	Sell
2018 Q3	$3.3M	Buy
2018 Q2	$1.38M	Hold
2018 Q1	$735K	Hold
2017 Q4	$424K	Hold
2017 Q3	$443K	Hold
2017 Q2	$473K	Hold
2017 Q1	$600K	Buy